1473 Investors following AstraZeneca. Share this News with them.
0
Like this story, share it with millions of investors on M3
AstraZeneca's new lab to host key research work
AstraZeneca's newly commissioned process R&D laboratory in Bangalore will play a key role in the development of its new drug portfolio, in particular the tuberculosis drug coming out of India, according to its top officials.
AstraZeneca 's newly commissioned process R&D laboratory in Bangalore will play a key role in the development of its new drug portfolio, in particular the tuberculosis drug coming out of India, according to its top officials.
The PR&D lab built at $ 15 million was launched by the company CEO, Mr David Brennan, on Wednesday; it is the fourth such for the company and the first outside Europe; two are in the UK and one in Sweden.
It will grow from the current 40 to 75 scientists soon.
Dr Jan Lundberg, Executive Vice-President, Discovery Research, said, "This investment is not the end."
Dr David Haywood, Global Vice-President, Global Process R&D, said the Bangalore group could later develop outsourcing capabilities for large-scale laboratory work in India. According to Dr Sudhir Nambiar, Director of the new lab, it will train pharma-biotech students in process safety.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| DLF | Suzlon Energy | Rafale | Sun Pharma | Singapore Telecommunications | Oil and Natural Gas Corporation | BSE Sensex | Iran | Reliance Power | Bonus share 
It will grow from the current 40 to 75 scientists soon. 
